Metabio

Metabio is rated 3 out of 5 in the category biotechnology. Read and write reviews about Metabio. Metabio has developed and validated an interoperability system for biobanks that works seamlessly with existing legacy systems. The system integrates data (patient, biosample, clinical) from multiple sources, for a data-product that is ontologically (HL7, open EHR) unified and longitudinally synchronized. As verified by biobanks, this data brings a much higher degree of accuracy and value for research and biobanks. Metabio’s system records and integrates data from each step of the collection process, establishing a chain of characterized, relational timeline data/donor. Our system’s online platform will receive data from, and offer it to: patients, biobanks, healthcare providers, and researchers. This platform adds value to specimens and acts as a biospecimen vendor and biobank aggregator. Pools of specimens and associated data from distinct biobanks are enriched and brought together in disease specific cohorts increasing inventory turnover margins, efficacy and value throughout the research cycle, leading to faster drug development. This unique technology creates a one-stop system for biospecimens and data, gathering data from multiple biobanks (disease-specific), patients (disease-progression), and hospitals (patients’ clinical data). This approach equips biobanks with the ability to provide collections of specimens that cover the entire cycle of diseases, thus raising value for all members of the health care chain.